Rare condition

Frontotemporal dementia, right temporal atrophy variant

0

studies recruiting now

as of 7 Sept 2026

0

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No registered studies found for Frontotemporal dementia, right temporal atrophy variant.

ClinicalTrials.gov has no study listed under this name as of 7 Sept 2026. That can change, and there are other routes worth knowing about.

Keep watching

Get an email when a new Frontotemporal dementia, right temporal atrophy variant study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Frontotemporal dementia, right temporal atrophy variant

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

11 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Memantine Hydrochloride (Akatinol)
Phase 3Latozinemab
Phase 3Hydromethylthionine Mesylate (Lmtx)
Phase 2Metformin
Phase 2Oxytocin (Orasthin)
Phase 2Sodium Chloride (Aqsia (balanced salt soln))
Phase 2Lithium Carbonate (Camcolit 250)
Phase 2Insulin Human (Actrapid)

+ 3 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).